10 patients in a subjective assessment of pain reduction? Wake up you guys! If you need more convincing take a look here: "Placebo-controlled clinical trials are the gold standard in drug development, in part to ensure that the efficacy of a new therapy exceeds the placebo response in the indication being studied. In osteoarthritis (OA), placebo treatment can result in pain reduction, functional improvement and stiffness reduction associated of up to 80% of the observed treatment efficacy. In fact, in randomized controlled trials, improvement perceived by OA patients taking placebo can be so great that some experts have suggested administration of placebo as a treatment option"
https://www.tools4patient.com/the-placebo-response-in-drug-development-part-2-osteoarthritis/
- Forums
- ASX - By Stock
- PAR
- Ann: EAP - 65% PAIN REDUCTION IN 10 OA PATIENTS IN USA
Ann: EAP - 65% PAIN REDUCTION IN 10 OA PATIENTS IN USA, page-156
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 22.0¢ | $34.69K | 154.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28174 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28174 | 0.225 |
7 | 211158 | 0.220 |
10 | 205052 | 0.215 |
12 | 169584 | 0.210 |
8 | 175200 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 25000 | 1 |
0.235 | 42540 | 3 |
0.240 | 93500 | 3 |
0.245 | 1000 | 1 |
0.250 | 89857 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online